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Mitochondria constantly respond to changes in
substrate availability and energy utilization to main-
tain cellular ATP supplies, and at the same time
control reactive oxygen radical (ROS) production.
Reversible phosphorylation of mitochondrial pro-
teins has been proposed to play a fundamental role
in metabolic homeostasis, but very little is known
about the signaling pathways involved. We show
here that protein kinase A (PKA) regulates ATP
production by phosphorylation of mitochondrial
proteins, including subunits of cytochrome c
oxidase. The cyclic AMP (cAMP), which activates
mitochondrial PKA, does not originate from cyto-
plasmic sources but is generated within mitochon-
dria by the carbon dioxide/bicarbonate-regulated
soluble adenylyl cyclase (sAC) in response to meta-
bolically generated carbon dioxide. We demonstrate
for the first time the existence of a CO2-HCO3
-sAC-
cAMP-PKA (mito-sAC) signaling cascade wholly
contained within mitochondria, which serves as
a metabolic sensor modulating ATP generation and
ROS production in response to nutrient availability.
INTRODUCTION
The Krebs Cycle (TCA cycle) produces the electron donors,
which drive mitochondrial production of ATP via oxidative phos-
phorylation (OXPHOS). OXPHOS is subject to complex regula-
tion, including short-term modulations essential for responding
to transient changes in nutritional availability, environmental
conditions, and energy requirements. If the reducing equivalents
generated by the TCA cycle are not efficiently utilized by the
OXPHOS machinery, reactive oxygen species (ROS) production
may increase, and oxidative damage may ensue. It has been
proposed that dynamic protein phosphorylation plays a major
role in these rapid modulations (Hopper et al., 2006).
Evidence has emerged suggesting that cyclic AMP (cAMP)-
mediated phosphorylation of mitochondrial enzymes plays
a role in OXPHOS regulation. Consistent with this hypothesis,
both protein kinase A (PKA) (reviewed in Pagliarini and Dixon,
2006; Thomson, 2002) and A kinase-anchoring proteins (AKAPs)have been identified in mammalian mitochondria (Feliciello et al.,
2005; Lewitt et al., 2001). In particular, PKA in the mitochondrial
matrix has been demonstrated by several independent groups
using biochemical, pharmacological, and immunological
methods, including immunoelectron microscopy (Livigni et al.,
2006; Prabu et al., 2006; Ryu et al., 2005; Schwoch et al.,
1990). However, if PKA plays a role in phosphorylatingmitochon-
drial proteins, it remains unclear how the cAMP that activates
PKA is modulated. Specifically, cAMP does not diffuse far from
its source (Bornfeldt, 2006; Zaccolo and Pozzan, 2002), and as
we show here, it does not enter mitochondria. Papa et al. postu-
lated that a source of this second messenger might reside inside
mitochondria (Papa et al., 1999), but an intramitochondrial
adenylyl cyclase had not been demonstrated so far.
In mammalian cells, cAMP can be produced by a family of
plasma membrane-bound forms of adenylyl cyclase (tmAC), or
by a ‘‘soluble’’ adenylyl cyclase (sAC) (Buck et al., 1999). We
previously showed that sAC resides at multiple subcellular
organelles, including mitochondria (Zippin et al., 2003). Unlike
tmACs, sAC is insensitive to heterotrimeric G protein regulation
or forskolin; instead, it is stimulated by bicarbonate (Chen
et al., 2000) and sensitive to ATP (Litvin et al., 2003) and calcium
levels (Jaiswal and Conti, 2003; Litvin et al., 2003). Bicarbonate
stimulates sAC activity by facilitating active site closure, while
calcium promotes activity by increasing the affinity for ATP (Litvin
et al., 2003; Steegborn et al., 2005). In physiological systems,
including mitochondria (Dodgson et al., 1980), carbonic anhy-
drases (CA) convert CO2 into bicarbonate. While generating
electron donors for OXPHOS, the TCA cycle generates CO2
and therefore bicarbonate. Thus, sAC represents an excellent
candidate OXPHOS regulator, which ensures that respiration
can keep pacewith changes in nutritional availability and prevent
ROS accumulation.
Here we show that PKA modulation of OXPHOS activity is
regulated by cAMP generated inside mitochondria by sAC in
response to metabolically generated CO2. This study provides
a functional understanding of the modulation of OXPHOS in
direct response to nutrient metabolism by the mito-sAC
signaling pathway.
RESULTS
cAMP-PKA Regulation of OXPHOS
To test whether mitochondrial OXPHOS can be modulated by
PKA, we stimulated HeLa cells with membrane-permeantCell Metabolism 9, 265–276, March 4, 2009 ª2009 Elsevier Inc. 265
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mt-cAMP Regulates OXPHOS8Br-cAMP, which activates all cAMP-dependent kinases. We
measured oxygen consumption as an indicator of mitochondrial
respiratory chain function. 8Br-cAMP (1 mM for 30 min) resulted
in a 25% (p < 0.0001) increase in oxygen consumption, as
compared to untreated cells (Figure 1A). Then, we uncoupled
oxygen consumption from ATP synthesis by inclusion of carbon-
ylcyanide-4-(trifluoromethoxy)-phenylhydrazone (FCCP). Under
these conditions, where respiratory chain activity is independent
from ATP synthesis by the F1F0 ATPase, 8Br-cAMP still
increased oxygen consumption. Note that the residual ATP
content inmitochondria treatedwith FCCP for 5minwas approx-
imately 60% of the pre-FCCP content (2.5 ± 0.3 and 4.1 ±
0.2 nmol/mg protein, respectively). Thus, there still was sufficient
ATP for phosphorylation of PKA target proteins. The exchange
protein activated by cAMP-selective agonist, 8CPT methyl-
cAMP, did not change coupled or uncoupled respiration.
Conversely, H89 at 1 mM, a concentration that selectively
blocks PKA, resulted in a 50% decrease in coupled and
uncoupled respiration. RpcAMP (25 mM), which inhibits PKA by
a different mechanism, also caused a significant decrease
(20%, p < 0.001) in oxygen consumption (data not shown). The
effects of PKA agonists and antagonists were replicated in
143B human osteosarcoma and 293T-HEK (data not shown),
except that the increase in respiration induced by FCCP was
higher (i.e., approximately 100% in 143B and 293T compared
to 20% in HeLa cells), reflecting different coupling between
oxygen consumption and ATP synthesis.
Stimulation of tmAC with forskolin in combination with the
phosphodiesterase (PDE) inhibitor 3-Isobutyl-1-methylxanthine
(IBMX) did not affect mitochondrial respiration, despite an 8- to
10-fold increase in cytoplasmic cAMP (Figure 1B). Therefore,
mitochondrial respiration is enhanced through PKA activation
by membrane-permeant cAMP analogs, but not by cytoplasmic
cAMP, suggesting that the PKA that modulates respiration is
inside mitochondria. It was suggested that tmAC-generated
cAMP enters the mitochondrial matrix. However, our data
demonstrate that cytoplasmic cAMP does not have access to
the intramitochondrial PKA pool. DiPilato and colleagues used
a reporter protein targeted to mitochondria, but the mitochon-
drial import was partial, with a portion of the protein remaining
on the cytosolic surface or in the mitochondrial intermembrane
space (DiPilato et al., 2004), where it remained accessible to
cytosolic cAMP.
To further explore the role of intramitochondrial PKA in modu-
latingOXPHOS, we examined isolatedmitochondria frommouse
liver.CFirst wemeasured state III (phosphorylating) respiration driven
by different substrates: glutamate/malate (G + M) specific for
complex I (Figure 1C), succinate for complex II (Figure 1D), and
TMPD + ascorbate for complex IV (Figure 1E). Similar to intact
cells, 8Br-cAMP produced a small but significant increase in
respiration with glutamate/malate (12%, p < 0.05) and TMPD/
ascorbate (13%, p < 0.05). Succinate-dependent respiration
was unchanged, indicating that it cannot be upregulated by
cAMP. As expected, addition of exogenous, membrane-imper-
meant cAMP, or 8CPT methyl-cAMP, or forskolin + IBMX had
no effect on oxygen consumption (Figures 1C–1E). Similar to
whole cells, the PKA inhibitor, H89, decreased oxygen
consumption driven by all complexes (44% for glutamate/
malate, p < 0.0001; 50% for succinate, p < 0.0001; 30% for
TMPD/ascorbate, p < 0.0001). Another PKA-specific inhibitor,
myristoylated PKI 14-22, also inhibited respiration (20% for
glutamate/malate, p < 0.001; 36% for succinate, p < 0.001;
25% for TMPD/ascorbate, p < 0.0001). 8Br-cAMP was inert in
the presence of PKI 14-22, confirming the role of PKA in modu-
lating respiration.
Second, we showed that ATP synthesis (Figure 1F) was also
enhanced by 8Br-cAMP (75%, p < 0.0001), inhibited by H89
and PKI 14-22 (63% and 74%, respectively, p < 0.0001), and
unchanged by membrane impermeant cAMP.
Third, the capacity to generate mitochondrial membrane
potential (DJm) was measured fluorimetrically under nonphos-
phorylating conditions. Figure 1G shows representative fluores-
cence traces. 8Br-cAMP increased membrane potential driven
by glutamate/malate or succinate (21% ± 8% and 29 ± 6%,
respectively; p < 0.01), whereas H89 decreased it (37% ± 8%
and 51% ± 10%, respectively; p < 0.0001).
Because PKA inhibitors decreased oxygen consumption inde-
pendent of which electron transfer complex was stimulated
(Figures 1C–1E), the modulating effect of PKA likely targets
COX, the terminal component of the respiratory chain. Consis-
tently, COX activity (rate of oxidation of reduced cytochrome c)
was stimulated by 8Br-cAMP (25%, p < 0.0001; Figure 1H), but
not by cAMP, 8CPT methyl-cAMP, or forskolin + IBMX, and was
inhibited by H89 and PKI 14-22 (22%% and 18%, respectively;
p < 0.0001). The stimulation by 8Br-cAMP was blocked by PKI
14-22.
There were no changes in steady-state protein levels of COX
subunits I and IV after modulation of PKA (Figure S1), suggesting
that the activity changes depend on posttranslational modifica-
tion of the enzyme kinetics. Consistently, it was previously
proposed that COX is regulated via protein phosphorylationFigure 1. Regulation of OXPHOS by cAMP-PKA Agonists and Antagonists
(A) Respiration (coupled and uncoupled) in HeLa cells after 8Br-cAMP (n = 6), 8CPT methyl-cAMP (8CPTm-cAMP) (n = 3), H89 (n = 6), for 0.5 hr or with forskolin +
IBMX (fsk-IBMX) (n = 3). Control, untreated cells (n = 33). Values are fmoles O2 per min per cell.
(B) Cellular cAMP levels after stimulation of tmAC with fsk-IBMX. Values are pmol cAMP per 106 cells.
(C–E) OXPHOS in mouse liver mitochondria. State III (phosphorylating) mitochondrial respiration driven by glutamate/malate (C); succinate (D), or TMPD/ascor-
bate (E). Compounded number of replicas were the following: control (n = 21); 8Br-cAMP (n = 9); cAMP (n = 3); 8CPTm-cAMP (n = 3); forskolin + IMBX (fsk + IBMX,
n = 3); H89 (n = 9); PKI 14-22 (n = 3); 8Br-cAMP + PKI (n = 3); KH7 (n = 9); KH7.15 (n = 3); and 8Br-cAMP + KH7 (n = 3).
(F) ATP synthesis with 8Br-cAMP (n = 3), cAMP (n = 3), H89 (n = 3), and PKI 14-22 (PKI, n = 3). Values are nmoles ATP per min per mg of mitochondrial protein.
(G) Safranin-O fluorescence curves showing changes in mitochondrial membrane potential (DJm) driven by G + M and inhibited by rotenone (Rot), or driven
by succinate (Succ) and blocked by the complex III inhibitor antimycin A (AA). Values are relative fluorescent units (RFU). The plots are representative of three
independent determinations, which showed similar responses.
(H) COX Vmax (IU per milligram of protein, n = 9). Error bars indicate standard deviations. *p < 0.05; **p < 0.001; ***p < 0.0001.ell Metabolism 9, 265–276, March 4, 2009 ª2009 Elsevier Inc. 267
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As expected for a short-term adaptation mechanism, the
cAMP-induced changes in PKA modulation of COX activity
were transient and readily reversible uponwashout of the agonist
(Figure S2).
sAC Is a Source of cAMP in Mitochondria
Membrane-impermeant cAMP had no effect on OXPHOS
response, suggesting that a source of cAMP must reside within
mitochondria. We previously showed that sAC immunoreactivity
colocalizes and sAC activity copurifies with mitochondria (Zippin
et al., 2003). We now show that western blotting using the R21
monoclonal anti-sAC antibody (Zippin et al., 2003) identifies
multiple bands in the liver homogenate (Figure 2A), consistent
with multiple sAC splice isoforms (Buck et al., 1999; Farrell
et al., 2008; Geng et al., 2005; Jaiswal and Conti, 2003).
However, purified mitochondria contained only one sAC isoform
A
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Figure 2. sAC Is Localized and Generates cAMP in
Mitochondria
(A) Mitochondria isolated from mouse liver after to two
rounds of Nycodenz gradient purification. Lanes 2, 3, 4,
and 5 were from the first round. Fractions 4.2, 4.3, 4.4,
and 4.5 were from a second round of purification of frac-
tion 4. Tim 23, mitochondrial marker. PDI, protein disulfide
isomerase; ER, marker; GAPDH, cytoplasmic marker;
Hom, homogenate.
(B) Expression of sACt-HA in total cell homogenate of tran-
siently transfected COS cells and in crude nontreated (nt)
mitochondrial fractions detected by R21 and HA anti-
bodies. PK, Proteinase K; T + PK, Triton X-100 and PK.
Hsp60 and Tim23 are markers of the matrix and the inner
membrane, respectively.
(C) cAMP levels in intact mouse liver mitochondria in the
presence of bicarbonate (HCO3
) or KH7. Values are
pmol cAMP per mg mitochondrial protein (n = 3).
(D) Mitoplasts purity tested using protein markers for the
different mitochondrial compartments: Hsp60 (matrix),
COXI (inner membrane), cytochrome c (Cyt c, intermem-
brane space), Tom40 (outer membrane). M, (intact mito-
chondria), Mp (mitoplasts), P-Mp (post-mitoplast fraction).
(E) Residual cAMP levels after 50 pmol cAMP were added
to a reaction mixture containing sonicated mitoplasts
(mitoplast) or no mitoplasts (control), with and without
PDE + calmodulin (PDE), IBMX, or KH7. n = 3 for each
reaction. Error bars indicate standard deviations.
***p < 0.0001.
of approximately 48kDa (Figure 2A, lane 4). This
bandwas confirmed inmitochondria highly puri-
fied by a second gradient step (Figure 2A, lanes
4.4). Instead, ER-rich fractions contained a
distinct sAC isoform migrating at approximately
35kDa (Figure 2A, lanes 2 and 3). Glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH)
was absent from the mitochondrial and ER frac-
tions excluding detectable contamination with
cytoplasmic proteins.
A highly active isoform of rat sAC (sACt) (Chaloupka et al.,
2006) containing an N-terminal HA tag was expressed in COS
cells. In cell homogenates (Figure 2B, lane 1) sACt was detected
both by the R21 and the HA antibodies. The crude mitochondrial
fraction contained the same immunoreactive sACt bands
(Figure 2B, lane 2). Likewise, endogenous PKA was detected
in the mitochondrial fraction (Figure 2B, lane 2). A proteinase K
protection assay performed on the mitochondrial fraction
showed that portions of sACt and endogenous PKA were resis-
tant to digestion, indicating that they resided in a protectedmito-
chondrial compartment (Figure 2B, lane 3). Detergent solubiliza-
tion of mitochondria allowed for complete digestion of sACt,
PKA, as well as hsp60 and Tim23, localized in the mitochondrial
matrix and inner membrane, respectively (Figure 2B, lane 4).
sAC is stimulated by bicarbonate (Chen et al., 2000), and ad-
enylyl cyclase activity in mouse liver mitochondria demonstrated
a significant bicarbonate stimulation (Figure 2C, p < 0.0001) and
inhibition by the sAC-specific inhibitor, KH7 (Hess et al., 2005),268 Cell Metabolism 9, 265–276, March 4, 2009 ª2009 Elsevier Inc.
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ically active.
The reversibility of the cAMP signal predicts that phosphodi-
esterase (PDE) should also be contained inside mitochondria.
To test this hypothesis we isolated mitoplasts (i.e., mitochondria
stripped of their outer membrane) from mouse liver. Mitoplasts
contained inner membrane and matrix proteins (COX I, and
Hsp60, respectively), but no intermembrane space or outer
membrane proteins (Cyt c and Tom40, respectively), whereas
the postmitoplasts supernatants only contained Cyt c and Tom
40 (Figure 2D). After the contents of thematrix weremade acces-
sible by sonication, they degraded exogenous cAMP (Figure 2E).
This cAMP catabolic activity was fully inhibited by IBMX, con-
firming the presence of intramitochondrial PDE activity.
Modulation of Intramitochondrial sAC
Regulates OXPHOS
We used two distinct methods of increasing intramitochondrial
sAC-generated cAMP to demonstrate a functional role for sAC
in modulating OXPHOS activity.
First, sACt was stably overexpressed in 293T-HEK cells, and
was found in both the whole cell homogenate and in isolated
mitochondria (Figure 3A, lanes hom and 4, respectively). sACt
overexpression increased respiration by approximately 25%
(Figure 3B, p < 0.0001), as compared to untransfected cells.
Consistently, COX activity (Figure 3C) and ATP synthesis
(Figure 3D) were also increased (by 28% and 87%, respectively;
p < 0.0001). These effects were antagonized by the sAC-specific
inhibitor, KH7.
Second, we stimulated endogenous mouse liver sAC in iso-
lated mitochondria with bicarbonate. We found that maximum
C D
BA
Figure 3. Transgenic sACt Localizes to Mitochon-
dria and Increases OXPHOS
(A) Localization of tsAC in untransfected (unstransf) and
sACt overexpressing (sACt) cells in homogenates (hom.
lane) and pure mitochondria from fraction 4 of the Nyco-
denz gradient (lane 4). The major 48 kDa immunoreactive
band corresponds to the molecular size of sACt. A similar
size band, faintly detectable in untransfected 293T cells,
presumably corresponds to an isoform of endogenous
sAC.
(B) Mitochondrial respiration was increased in cells
expressing sACt in comparison to untransfected ones
(n = 9) in a KH7-sensitive manner (n = 3). sACt overexpres-
sion stimulated COX-specific activity (C, n = 9) and ATP
synthesis (D, n = 9). The increase in both COX and ATP
synthesis was KH7 sensitive (n = 3, C and D). Error bars
indicate standard deviations. ***p < 0.0001.
stimulation of COX activity occurred at 30 mM
bicarbonate (Figure 4A), which is consistent
with the physiological intramitochondrial bicar-
bonate concentration (ranges between 10 and
40 mM) (Simpson and Hager, 1979). As pre-
dicted, bicarbonate enhanced ATP synthesis
by 32% (Figure 4B, p < 0.001), and bicar-
bonate-dependent stimulation of COX activity
at least partially accounted for this effect (18%) (Figure 4C,
p < 0.001).
To confirm that bicarbonate stimulates OXPHOS, isolated
mitochondria were exposed to the CO2-generating combination
of a-ketoglutarate dehydrogenase complex (KGDHC), its
substrates ketoglutaric acid + NAD+, and its cofactors coen-
zyme-A and cocarboxylase. KGDHC stimulated COX-driven
respiration by 32%, using TMPD/ascorbate as substrates
(Figures 4D and 4E, p < 0.0001). Addition of the carbonic anhy-
drase inhibitor (CAI) acetazolamide diminished COX driven
respiration by 10% (p < 0.01), indicating that CO2 diffusing
through the mitochondrial membranes is converted into bicar-
bonate that activates sAC and stimulates COX.
We note that, since OXPHOS activity is increased by both
bicarbonate and by exogenously generated CO2, in a carbonic
anhydrase-dependent manner, these effects cannot be due to
pH changes (or ionic strength), because bicarbonate addition
increases pH while CO2 addition decreases it.
To further demonstrate the role of sAC inmodulating OXPHOS
activity, we used three independent methods of blocking intra-
mitochondrial sAC.
First, KH7, but not an inactive congener, KH7.15 (Wu et al.,
2006), inhibited state III respiration driven by complexes I, II,
and IV by 25%, 22%, and 35%, respectively (Figure 1C–1E,
p < 0.0001). Inhibition of sAC by KH7 also markedly decreased
ATP synthesis (80%) (Figure 4B, p < 0.0001). KH7, but not
KH7.15, inhibited COX activity by 30% (Figure 4C, p < 0.0001).
In each case, KH7 inhibition was rescued by membrane perme-
able 8Br-cAMP. Finally, KH7 decreased DJm in isolated mito-
chondria by 46% ± 6% with glutamate/malate and by 62% ±
11% with succinate (Figure 1G, p < 0.0001). The effects of sACCell Metabolism 9, 265–276, March 4, 2009 ª2009 Elsevier Inc. 269
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Figure 4. CO2-TCA and sAC Modulation Regulates OXPHOS
(A) COX Vmax in isolated mitochondria treated with increasing concentration of HCO3
, from 5 mM to 40 mM (n = 6).
(B and C) Isolated mitochondria from mouse liver incubated with bicarbonate (HCO3
) (n = 4), or NaCl (n = 3) or KH7, (n = 9), KH7.15, (n = 3), KH7 + 8Br-cAMP
(n = 3). ATP synthesis (B) was increased by HCO3
 treatment, whereas KH7 inhibited it. COX Vmax was increased by HCO3
, whereas KH7 diminished it (C). COX
Vmax decrease was not observed with KH7.15, and was rescued by 8Br-cAMP.
(D) A representative trace of respiration driven by COX using TMPD/ascorbate mouse liver mitochondria. AA is added tomitochondria before TMPD/ascorbate to
block electron transfer upstream of COX. KCN is added at the end to inhibit COX. Each addition is marked by downward arrowheads.
(E) Quantification of the experiments shown in D (n = 9).
(F) KH7 (n = 6) reduced respiration in intact HeLa cells, and this inhibition was prevented by 8Br-cAMP (n = 3), but not by forskolin + IBMX (n = 3). Control,
untreated cells (n = 33).
(G) COX activity in intact or sonicated mitochondria with or without the inhibitory anti-sAC antibody R21. HCO3
 stimulation of COX was antibody insensitive in
intact mitochondria, whereas it was abolished in sonicated mitochondria by R21 (n = 3).
(H) COX activity in intact or sonicated mitochondria with or without PDE. HCO3
 stimulation of COX was PDE insensitive in intact mitochondria, whereas it was
abolished in sonicated mitochondria by PDE. IBMX prevented the PDE-mediated decrease in COX activity (n = 3).
(I) cAMP levels in sonicated mitochondria were increased by HCO3
 and reduced by PDE. IBMX prevented the decrease in cAMP. Values expressed as pmol
cAMP per mg mitochondrial protein (n = 5). Error bars indicate standard deviations. *p < 0.05; **p < 0.001; ***p < 0.0001.270 Cell Metabolism 9, 265–276, March 4, 2009 ª2009 Elsevier Inc.
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cells, where KH7 induced a 30% decrease, which was rescued
by 8Br-cAMP but not by cytosolic cAMP induced by forskolin +
IBMX (Figure 4F, p < 0.0001).
As a second independent method of blocking sAC activity, we
used the anti-sACmonoclonal R21antibody, which has inhibitory
properties on enzymatic activity (Figure S3). Neither R21 nor
nonspecific isotype-matched IgG caused COX inhibition in intact
mitochondria. However, R21, but not the IgG control, blocked
the bicarbonate-induced increase in COX activity when sAC
was made accessible to the antibody by mitochondrial sonica-
tion (Figure 4G, p < 0.01).
Third, we measured COX activity in mitochondria treated with
bicarbonate in the presence or absence of PDE. In intact mito-
chondria, bicarbonate stimulated COX activity was unaffected
byPDE (Figure 4H). Thus, cAMPwas produced in a compartment
isolated from external PDE. After sonication, PDE degraded
intramitochondrial cAMP (Figure 4I, p < 0.001), and the bicar-
bonate-induced COX stimulation was abolished (Figure 4H), in
an IBMX sensitive manner.
Taken together, this evidence indicates that the sAC-cAMP-
PKA signaling pathway is wholly contained within mitochondria
and that it modulates OXPHOS in response to physiologically
relevant concentrations of bicarbonate.
cAMP-Dependent Phosphorylation of Mitochondrial
Proteins
We investigated the pattern of PKA-dependent mitochondrial
protein phosphorylation in isolated mitochondria. Proteins
were resolved by isoelectric focusing two-dimensional electro-
phoresis and detected with a PKA substrate-specific anti-phos-
pho Ser/Thr antibody (Bruce et al., 2002; Schmitt and Stork,
2002). Several of the PKA-phosphorylated proteins detectable
in untreated mitochondria (indicated by arrows in Figure S4A,
upper panel) disappeared or were markedly reduced in the
KH7-treated samples (Figure S4A, lower panel).
Many hydrophobic subunits of the respiratory chain are
not amenable to isoelectric focusing (unpublished data). There-
fore, to examine respiratory chain complexes, we employed
2D-blue-native gel electrophoresis (Schagger and Pfeiffer,
2000; Schagger and von Jagow, 1991). Phosphoproteins
were detected using either anti-phospho Ser/Thr antibody (Fig-
ure S5A) or the PKA substrate-specific antibody (Figure S5B).
Replicate sampleswere treatedwith calf-intestinal phosphatase,
which abolished most immunoreactive spots on the membrane
probed with anti-phospho Ser/Thr antibody, demonstrating
the specificity of the antibody (Figure S6). Both anti-phospho
Ser/Thr and the PKA substrate-specific antibodies revealed
a marked decrease of several phosphoproteins after KH7 or
H89. Membranes were reprobed with antibodies against COX
subunits, which revealed two of the phosphorylated proteins
(denoted by asterisks in the upper panel of Figure S5A) to be
COX I and COX IV type II (COX IV-2). The amounts of phosphor-
ylatedCOX IandCOX IV-2were respectively reduced to30%and
20% with H89, and to 25% and 5% with KH7.
These results confirm that phosphorylation of several mito-
chondrial proteins responds to modulation of the mito-sAC
signaling pathway and suggest that certain COX subunits are
candidates for the regulation of OXPHOS activity.Physiological Role of the Intramitochondrial Mito-sAC
Pathway in the Regulation of OXPHOS and ROS
Production
We hypothesized that the physiological role of mitochondrial
sAC is to respond to CO2 metabolically generated by the TCA
cycle. To test this hypothesis, we measured COX activity in iso-
lated mitochondria ‘‘fed’’ with pyruvate and malate, which fuel
the TCA cycle to stimulate CO2 generation. Under these condi-
tions, CAI diminished COX activity by 37% (Figure 5A, p <
0.001), suggesting that the CO2 had to be converted to bicar-
bonate to sustain COX activity. The inhibitory effect of CAI was
reversed by exogenous bicarbonate, which directly stimulates
sAC, or by the addition of 8Br-cAMP, which bypasses sAC stim-
ulation. Diminishing CO2 production by retrograde inhibition of
the TCA cycle using the complex III blocker antimycin A (AA)
reduced COX activity (25%, p < 0.001). As with CAI addition,
AA inhibition was rescued by the bicarbonate or 8Br-cAMP
(Figure 5A, p < 0.01). Changes in mitochondrial cAMP levels
paralleled the changes in COX activity; cAMP decreased in the
presence of CAI or AA, demonstrating that TCA cycle-generated
CO2 regulates sAC (Figure 5B, p < 0.0001). Finally, OXPHOS
was inhibited by CAI also in intact cells, where respiration was
diminished by 36% and rescued by 8Br-cAMP (Figure 5C,
p < 0.0001).
To investigate the role of the mito-sAC signaling pathway in
the physiological adaptation to changes in substrate availability,
we cultured cells in medium containing galactose instead of
glucose as the main carbon source. Because galactose is
utilized in the glycolytic pathway at a much slower rate than
glucose, cells are forced to maximize mitochondrial OXPHOS
activity to meet their energy needs. Consistently, respiration
was increased by 35% in galactose as compared to glucose
medium (Figure 5D, p < 0.0001). In contrast to cells grown in
glucose, respiration in cells grown in galactose for 48 hr was
unaffected by 8Br-cAMP. Presumably, these cells are insensitive
to stimulation because OXPHOS is already fully activated by the
mito-sAC signaling pathway. Consistently, the decrease in respi-
ration resulting from inhibition of CA, sAC, or PKA was propor-
tionally more effective in galactose than in glucose (46.8% ±
3.97% and 36.5% ± 3.87%, respectively, p < 0.0001).
Activation of the TCA cycle dehydrogenases by increasing
mitochondrial calcium (McCormack et al., 1990) with the calcium
ionophore A23187 (0.5 mM) stimulated respiration in glucose
(Figure 5D, p < 0.0001), but not in galactose, because in the latter
there was no spare respiratory capacity. Alternatively, calcium
could stimulate respiration by uncoupling due to calcium cycling.
However, it is unlikely that this mechanism would be sensitive to
all three inhibitors of the mito-sAC pathway, which suppress
respiration both in glucose and galactose medium. Thus, the
only nonconflicting explanation is that the mito-sAC pathway
modulates the terminal oxidase of the respiratory chain, which
is known to be limiting for respiration in cells (D’Aurelio et al.,
2001; Villani and Attardi, 1997; Villani et al., 1998).
Mito-sAC signaling cascade links substrates flux through the
TCA cycle with the rate of OXPHOS activity; this linkage could
be beneficial to minimize electron leakage from the respiratory
chain and prevent ROS generation. Cells grown in galactose
produced less ROS than cells grown in glucose (Figure 5E,
p < 0.0001), but ROS production in glucose was diminished byCell Metabolism 9, 265–276, March 4, 2009 ª2009 Elsevier Inc. 271
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Figure 5. Physiological Role of the Intramitochondrial mito-sAC Pathway in the Regulation of OXPHOS and ROS Production
(A) COX Vmax in mouse liver mitochondria with CAI (n = 9), CAI + HCO3
 (n = 9) and CAI + 8Br-cAMP (n = 9), and pyruvate and malate as substrates. CAI
decreased COX activity, which was rescued by HCO3
 or 8Br-cAMP. AA (n = 6), blocked CO2 production by the TCA cycle and decreased COX activity, which
was rescued by HCO3
 or 8Br-cAMP.
(B) cAMP levels in mitochondria decreased when CA or the TCA cycle were blocked with CAI and AA, respectively. HCO3
 reverted the effects of CAI or
AA (n = 8).
(C) CAI (n = 6) decreased respiration in HeLa cells, and this inhibition was prevented by 8Br-cAMP (n = 3). Control, untreated cells (n = 33).
(D) Respiration in cells grown in glucose or galactose medium (black bars) (n = 6) for 48 hr. The calcium ionophore A23187 (dashed bars) increased respiration in
control (untreated) cells in glucose.
(E) ROS production in cells grown in glucose or galactose and treated as in (D) (n = 6). Galactose resulted in decreased ROS production in control cells (black
bars). All other comparisons are between treated and untreated cells grown under the same conditions (i.e., glucose or galactose medium). Error bars indicate
standard deviations. *p < 0.05; **p < 0.001; ***p < 0.0001.8Br-cAMP. Addition of 8Br-cAMP to galactose grown cells,
whose OXPHOS is already maximally stimulated, had no effect.
Consistent with the hypothesis that ROS production depends on
themito-sAC pathway, CAI, KH7, or H89 increasedROSproduc-
tion both in glucose and in galactose (Figure 5E, p < 0.001), and
8Br-cAMP reverted the effects of CAI and KH7 on ROS produc-
tion, but not those of H89, because its inhibition is downstream
of cAMP.
Taken together these results indicate that the mito-sAC
pathway is engaged in the adaptation of OXPHOS activity in
order to optimize the use of substrates for bioenergetic purposes
and, at the same time, minimize ROS production.272 Cell Metabolism 9, 265–276, March 4, 2009 ª2009 Elsevier Inc.DISCUSSION
Which are the players involved in the phosphorylation-mediated
regulation of OXPHOS function? While many putative mitochon-
drial phosphoproteins have been identified, most of them have
been demonstrated in vitro, making their physiological relevance
uncertain. Similarly, the list of kinases and phosphatases identi-
fied in mitochondria is constantly expanding (Pagliarini and
Dixon, 2006), but their physiological role is still largely unidenti-
fied. For example, while both PKA (Livigni et al., 2006; Pagliarini
and Dixon, 2006; Prabu et al., 2006; Ryu et al., 2005; Schwoch
et al., 1990) and A kinase-anchoring proteins (AKAPs) (Feliciello
Cell Metabolism
mt-cAMP Regulates OXPHOSet al., 2005; Wang et al., 2001) were found in mitochondria, their
substrates and physiological relevance remained controversial.
We now show that PKA regulates OXPHOS and that cAMP is
generated inside mitochondria in response to metabolically
generated CO2.
We identify sAC as a source of cAMP inside mitochondria. We
established the presence and the function of sAC in mitochon-
dria by three independent criteria: (1) sAC is localized inside
mitochondria, (2) OXPHOS is decreased by sAC inhibition, and
(3) the sAC activator bicarbonate stimulates OXPHOS.
Which are the targets of the mito-sAC pathway? A number of
cAMP-dependent phosphorylation events of respiratory chain
components have been described. Much work has focused on
small subunits of complex I (Papa et al., 1996; Sardanelli et al.,
1995; Scacco et al., 2000; Signorile et al., 2002; Chen et al.,
2004), although it still remains to be studied whether any of the
complex I phosphorylation events are dependent upon the
mito-sAC pathway.
Our initial proteomic work has focused on COX, another respi-
ratory chain complex, whose phosphorylation has been studied.
COX subunits I, IV-1, and Vb are phosphorylated by PKA in
hypoxic cells, resulting in decreased steady-state levels of these
proteins and thus COX activity (Prabu et al., 2006). However,
changes in COX protein steady-state levels do not occur in our
system; therefore, these phosphorylations are unlikely to
contribute to the effects described here. Another cAMP-depen-
dent phosphorylation event of COX subunit I occurs on tyrosine
residue 304, via PKA regulation of a tyrosine kinase or phospha-
tase. Tyrosine 304 phosphorylation results in COX inhibition
in vitro. However, this tyrosine is on the outer face of the mito-
chondrial inner membrane (Lee et al., 2005), implying that its
phosphorylation should not be dependent upon intramitochon-
drial cAMP.
cAMP-dependent phosphorylation of subunit I of COX has
been postulated to optimize OXPHOS efficiency by keeping
the mitochondrial membrane potential low while complex I is
fully activated (Bender and Kadenbach, 2000; Kadenbach,
2003). It was also shown that phosphorylation of subunit II of
COX by mitochondrial c-Src results in enhanced COX activity
in a cAMP-dependent manner (Miyazaki et al., 2003). Either of
these mechanisms may be contributing to the increased COX
activity described here. COX subunits IV (at amino acid Ser34)
and Va (at amino acids Ser4 and Thr35) subunits are phosphor-
ylated in vitro by PKA (Helling et al., 2008). The physiological
consequence of these phosphorylation events remains
unknown, but because these residues are located on the matrix
side of the enzyme (Shinzawa-Itoh et al., 2007), they may be
subject to regulation by intramitochondrial PKA.
The mito-sAC pathway is sensitive to metabolic conditions
that affect CO2 production. CO2 would diffuse throughout
a cell, but as it diffuses it encounters discretely localized CA,
which speeds up the hydration and dissociation into H+ and
bicarbonate. Thus, diffusing CO2 would establish a new equilib-
rium, with elevated bicarbonate wherever it encounters CA.
Such bicarbonate elevation would be transient, as bicarbonate
would reach a new equilibrium as a function of the changing local
PCO2, pH, and buffer capacity. Our data indicate that this occurs
within the mitochondrial matrix in response to metabolically
generated CO2. Due to intramitochondrial CA (Dodgson et al.,C1980), bicarbonate fluctuates inside mitochondria in direct
proportion to the CO2 generated via the TCA cycle and b-oxida-
tion, and these transient elevations of bicarbonate activate sAC
to increase OXPHOS activity and ATP synthesis (Figure 6).
In the well-fed mouse livers used in this study, the mito-sAC
pathway appears to be mostly in the ‘‘active’’ state, with high
constitutive protein phosphorylation. Thus, we observe a propor-
tionally lower stimulation of OXPHOS by membrane permeable
cAMP, bicarbonate, or CO2 (Figure 1), than downregulation by
inhibition of the TCA cycle, carbonic anhydrases, sAC, or PKA
(Figures 1 and 4). Physiologically, this pathway mediates
OXPHOS activation in response to stimulation of mitochondrial
dehydrogenases and utilization of the mitochondrial spare respi-
ratory capacity in cells forced to depend upon OXPHOS for
survival in galactose medium. In addition, by providing a mecha-
nism for coupling nutrient utilization with the electron flux, the
mito-sAC pathway controls ROS production by the respiratory
chain.
With the demonstration that PDE resides inside mitochondria,
along with sAC and PKA, we have identified a cAMP microdo-
main wholly contained within mitochondria. To our knowledge,
this represents the first description of a complete signaling
cascade inside this organelle. We predict that other itramito-
chondrial signaling cascades will be identified, which may have
evolved in eukaryotes subsequent to endosymbiosis or been
retained from primordial bacteria (Margulis and Bermudes,
1985). Interestingly, mammalian sAC is more closely related to
Figure 6. Diagram of the Proposed mito-sAC Regulatory Pathway of
OXPHOS
Activators and inhibitors of the various steps of the mito-sAC pathway are
indicated. PM, plasma membrane; OM, outer mitochondrial membrane;
IMS, inter membrane space; IM, inner mitochondrial membrane; PKA, protein
kinase A; sAC, soluble adenylyl cyclase; CA, carbonic anhydrase; KH7, inhib-
itor of sAC; H89 and PKI (PKI 14-22), inhibitors of PKA; PDE, phosphodies-
terase. I through V indicate respiratory chain complexes (I-IV) and complex V
(ATPase).ell Metabolism 9, 265–276, March 4, 2009 ª2009 Elsevier Inc. 273
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otidyl cyclases (Buck et al., 1999), and its mechanisms of
calcium and bicarbonate regulation are conserved in cyanobac-
teria (Chen et al., 2000; Steegborn et al., 2005).
By linking nutrient metabolism with ATP synthesis and ROS
production, the function of the mito-sAC signaling pathway
ensures a proper balance between the supply of reducing equiv-
alent to the electron transport chain and their utilization. This
feed forward regulation may have profound implications for
energy metabolism in eukaryotic cells.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
HeLa, human embryonic kidney (HEK293T), and COS-1 cells were grown in
Dulbecco modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), L-glutamine, 1 mM pyruvate, and 4.5 g/L glucose.
HEK293T cells expressing sACt were generated by stable transfection as
previously described (Hess et al., 2005). COS-1 cells were transiently trans-
fected with a pTurbo plasmid containing sACt cDNA with an HA tag, using
FuGene6 (Roche) following the manufacturer’s protocol. Cells were harvested
for fractionation and immunoblots after 72 hr.
For galactose growth experiments, HeLa cells were cultured in DMEM
without glucose and supplemented with 4.5 g/L galactose, 1 mM pyruvate,
L-glutamine, and 10% dyalized FBS.
Measurements of OXPHOS Function in Cells
and Isolated Mitochondria
Intact cells (23 106) were used for O2 consumption measurements in an oxy-
graph equipped with a Clark electrode, as described (Hofhaus et al., 1996).
Mouse liver mitochondria were isolated as described (Fernandez-Vizarra
et al., 2002) and state III O2 consumption driven by specific respiratory chain
complexes wasmeasured on 75–100 mg of mitochondrial protein as described
(Hofhaus et al., 1996). The calcium ionophore, A23187, was used at 0.5 mM. All
reagents were purchased from Sigma-Aldrich.
COX enzymatic activity was measured spectrophotometrically on isolated
mitochondrial (2–5 mg of protein) or in cell lysates (30–50 mg of protein) as
described (Birch-Machin and Turnbull, 2001).
ATP synthesis in isolated mitochondria (15–25 mg of protein) or in cells per-
meabilized with digitonin (23 106 cells) was measured using a kinetic lumines-
cence assay, as described (Vives-Bauza et al., 2007).
ATP content was measured in isolated mouse liver mitochondria incubated
with and without the addition of 3 mM FCCP for 5 min using the Enliten ATP
Determination Kit (Promega) as described (Vives-Bauza et al., 2007).
Titration of Agonists and Inhibitors
Each agonist and inhibitor used in this study was titrated to determine condi-
tions resulting in a maximal effect on OXPHOS. All experiments, including
those where bicarbonate was added, were performed at constant pH and
under ambient CO2.
In intact cells, titrations of compounds were performed by following mito-
chondrial O2 consumption. The concentrations of agonists/inhibitors used
were as follows: 8Br-cAMP (Sigma-Aldrich), 1 mM; H89 (Calbiochem), 1 mM;
RpcAMP (Sigma-Aldrich), 25 mM; KH7, 50 mM; 8-CPT-methyl-cAMP (BioMol
International), 1 mM; forskolin (Sigma-Aldrich), 10 mM; 3-Isobutyl-1-methyl-
xanthine (IBMX, Sigma-Aldrich), 50 mM, acetazolamide (carbonic anhydrase
inhibitor, CAI, Sigma-Aldrich), 1 mM for 0.5 hr.
Isolated mitochondria were incubated with PKA agonists and inhibitors in
MAITE medium (10 mM Tris-HCl, pH 7.4; 25 mM sucrose; 75mM sorbitol;
100 mM KCl; 10 mM K2HPO4; 0.05 mM EDTA; 5 mM MgCl2; 1 mg/ml BSA)
in the presence of a cocktail of phosphatase inhibitors (Sigma-Aldrich).
When bicarbonate was used to stimulate sAC, MAITE containing 300 mM
Tris-HCl was used to buffer the pH. Controls for bicarbonate were also run
in MAITE 300 mM Tris-HCl. The following conditions were used for all experi-
ments: 1 mM 8Br-cAMP, 1 mM H89, 25 mM KH7, and 30 mM bicarbonate for
10 min. Other agonist/inhibitors used in this study were as follows: cAMP274 Cell Metabolism 9, 265–276, March 4, 2009 ª2009 Elsevier Inc.(Sigma-Aldrich), 1 mM; 8-CPT-methyl-cAMP, 1 mM, forskolin, 10 mM + IBMX
50 mM; myristoylated protein kinase inhibitor peptide 14-22 (PKI 14-22,
Sigma-Aldrich), 1 mM; KH7.15 25, 1 mM; acetazolamide (CAI), 1 mM.
Membrane Potential Measurements
Mitochondrial membrane potential (DJm) was measured in enriched mouse
mitochondrial fractions using the dye Safranin-O as previously described
(Kwong et al., 2007). DJm was calculated based on the linear response of
the dye Safranin-O in the region of our measurements (50–170 mV), corre-
sponding to the difference between the maximal fluorescence induced by
the substrates and the minimum fluorescence determined by the inhibitors
(Akerman and Wikstrom, 1976; Nedergaard, 1983; Zanotti and Azzone,
1980). Changes in DJm were expressed as a percentage of the untreated
mitochondria.
Mitochondrial Purification by Nycodenz Gradient
Crude mitochondria from mouse liver (5 mg) or cultured cells (1 mg) were
resuspended in 3.3 ml of 25%Nycodenz solution (50% stock, Gentaur) diluted
in 0.25 M sucrose, 1 mM EDTA, 10 mM HEPES-NaOH, pH 7.4. Resuspended
mitochondria were applied to a discontinuous Nycodenz gradient composed
of the following layers: 1.6 ml of 40%, 1.6 ml of 34%, 2.3 ml of 30%, 3.3 ml
of resuspended mitochondria, 2.3 ml of 23%, and 0.7 ml of 20% Nycodenz.
Samples were centrifuged at 95,000 g for 2 hr in a SW4ITi Sorvall Rotor, and
the following fractions were collected: fraction 2 between 20%–23%, fraction
3 between 23%–25%, fraction 4 between 25%–30% and fraction 5 between
30%–34%. Fraction 4 from mouse liver mitochondria was subjected to
a second round of Nycodenz gradient fractionation and fractions 2, 3, 4, and
5 (denoted as 4.2, 4.3, 4.4, and 4.5, respectively) were collected.
Mitoplast Preparation
Isolated mitochondria 500 mg (1 mg/ml) were resuspended in MS-EGTA
(225 mMmannitol, 75 mM sucrose, 5 mMHEPES, 1 mM EGTA, pH 7.4). Water
(1/10 volume) and digitonin (1 mg digitonin/5 mg mitochondrial protein) were
added, and the mixture was incubated on ice for 45 min. Then, KCl
(150 mM) was added, followed by incubation for 2 min on ice and centrifuga-
tion at 18,000 g for 20 min at 4C. The pellet containing the mitoplats fraction
was resuspended at 1 mg/ml in 300 mM Tris-HCl, 10 mM CaCl2, pH 7.4. The
supernatant containing the postmitoplasts fraction was precipitated with
12% TCA and centrifuged at 18,000 g for 15 min at 4C. The pellet was resus-
pended in 500 ml acetone and centrifuged at 18,000 g for 15 min at 4C.
Determination of Phosphodiesterase Activity in Isolated Mitoplasts
Mitoplasts were sonicated, and 50 pmol of cAMP was added to each sample.
IBMX (50 mM) or KH7 (25 mM) were used to prevent degradation and synthesis
of cAMP, respectively. Samples containing 50 pmol cAMP, 0.1 unit of phos-
phodiesterase (PDE, Sigma-Aldrich), and 10 units of calmodulin (Sigma-
Aldrich), with or without IBMX (but nomitoplasts) were used as controls. Reac-
tions were performed at 30C for 30 min.
Immunoblot Analyses
For western blot analyses of COX subunits in crude mitochondria, 10 mg of
protein were separated by 12.5% SDS-polyacrylamide gel electrophoresis
(PAGE) and electroblotted onto PVDF filters (BioRad).
For protease protection assays 20 mg of mitochondrial protein from COS
cells expressing sACt-HA were treated with 20 mg/ml PK for 20 min on ice.
Then, PK was inactivated with 2mM phenylmethanesulphonylfluoride for
10 min on ice. Prior to PK treatment, one aliquot of mitochondria was solubi-
lized with 1% Triton X-100 (Sigma-Aldrich) for 15 min on ice.
For isoelectric focusing of mitochondrial samples, 100 mg of protein were
processed with a Ready Prep 2D Cleanup kit (BioRad) and resuspended in
125 ml of rehydratation buffer (BioRad). Samples were applied to 3–10 IPG
strips (BioRad) and incubated overnight at room temperature. Isoelectric
focusing and 2D SDS-PAGEwere run under standard conditions, and proteins
were transferred onto a PVDF filters.
For blue native (BN) 2D gels (Schagger and von Jagow, 1991), 50–75 mg
mitochondrial protein were applied on a 5%–13% gradient BN gel followed
by a 12.5% 2D denaturing gel. After electrophoresis, proteins were electro-
blotted onto PVDF filters and sequentially probed with specific antibodies.
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37C to dephosphorylate mitochondrial proteins.
For protein detection, the following antibodies were used: R21 against
human sAC (Zippin et al., 2003), PKA (Millipore), phospho Ser/Thr residues,
Tim 23 (BD Transduction Laboratories), phospho Ser/Thr PKA substrate-
specific (Cell Signaling Technology), COX I, COX IV-2, GAPDH, and VDAC
(Invitrogen), PDI, Hsp60 and cytochrome c (Stressgen), HA (AbCam), and
Tom 40 (Santa Cruz Biotechnology).
Phosphodiesterase and Anti-sAC Antibody Treatment of Isolated
Mitochondria
Isolated crude mouse liver mitochondria (500 mg), either intact or sonicated
with three pulses of 2 s each at half of maximal frequency in a Branson Sonifier
250 sonicator (VWR Scientific), were resuspended in 300 mM Tris-HCl, 10 mM
CaCl2, pH 7.4 (1 mg/ml final concentration), and incubated with or without
0.1 unit of phosphodiesterase at 30C for 30 min. Ten units of calmodulin,
a PDE cofactor, were added to all samples. Bicarbonate (30 mM) and IBMX
(50 mM) were added to stimulate sAC or inhibit PDE, respectively. For immu-
noinhibition of sAC, samples were treated with 0.5 mg of the R21 anti-sAC anti-
body or with mouse IgG subtype K (Sigma). Phosphatase inhibitors were used
during the incubations.
Titration of R21 Antibody
Cyclase assays were performed in 100 ml volume with equivalent amounts of
total protein in the presence of 50mMTris (pH 7.5), 20mMcreatine phosphate,
and 100 U/mL CPK where required, substrate 2.5 mM [a32P]ATP and 10 mM
MgCl2. Reactions were incubated at 30
C for 30 min, and stopped with
200 ml 2% SDS. [32P]cAMP was recovered using a two-column methods as
described in (Salomon, 1979). Kinetic analysis was performed using GraphPad
Prism software.
a-Ketoglutarate Dehydogenase Complex Activity Treatment
of Isolated Mitochondria
a-ketoglutarate dehydogenase complex (KGDHC) activity was perform in the
oxygraph in respiration medium containing cocarboxilase (TPP, Sigma-
Aldrich), 0.3 mM: b-nicotidamide adenine dinucleotide (b-NAD+, Sigma-
Aldrich), 0.5 mM; coenzyme A (Sigma-Aldrich), 0.24 mM; a-ketoglutarate
(Sigma-Aldrich), 5mM; dithiothreitol (DTT, Sigma-Aldrich), 1 mM; and 0.5 units
of KGDHC (Sigma-Aldrich). After 3 min reaction, isolated crude mouse mito-
chondria (100 mg) were added to the medium and TMPD/ascorbate-depen-
dent respiration was measured after blocking complex III with antimycin A
as described above. Control samples were run in the same conditions, but
in the absence of the KGDHC enzyme.
cAMP Measurements
cAMP measurements were performed according to manufacturer’s instruc-
tions using the Direct Correlate-EIA cAMP Kit (Assay Designs, Inc.). One
hundred microliters of sample were measured. If necessary, samples were
diluted to bring the cAMP level of the sample within the linear range of the
assay.
ROS Production Determination
Cells were grown in glucose or galactose medium for 48 hr in a 96-well plate
and then incubated with the different compounds for 2 hr at the same concen-
trations used for the other biochemical assays. Cells were incubated with 20,70-
dichloroflourescein diacetate (H2-DCFDA; Invitrogen, 10 mM, 30 min) and then
washed with PBS. Fluorescence was measured in a Perkin Elmer HST7000
plate reader (excitation, 485 nm; emission, 535 nm). For each sample, values
were normalized by the maximal fluorescence measured after adding 300 mM
H2O2 for 15 min to correct for potential differences in the loading of the dye.
Statistical Analyses
Comparisons between groups were made using one-way ANOVA. Pair-wise
comparisons were made by post hoc Fisher PLSD test. Differences were
considered statistically significant at p < 0.05. Data analyses were performed
using the statistical program StatView. In all experiments, error bars indicate
standard deviations (Adept Scientific, UK).CSUPPLEMENTAL DATA
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